Why does this broker say to sell Cochlear (ASX:COH) shares in 2022?

Can Cochlear defy this broker's odds?

| More on:
a young boy in profile shows the cochlear implant devide fitted to his ear and attached to the side of his head to help him to process sounds.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Cochlear share price has held its gains over the last 12 months
  • One broker is downbeat on the outlook for the company's shares for 2022
  • But not all brokers are as pessimistic. 

Shares in hearing technology player Cochlear Limited (ASX: COH) are edging ahead today and, at the time of writing, are 0.46% in the green at $215.44 apiece.

Unlike many of its S&P ASX 200 Index (ASX: XJO) peers, the Cochlear share price has held gains across the last 12 months and into the new year. This year to date, Cochlear shares are flat whereas, in the previous year, they climbed 8%.

Despite their positive momentum on the chart, one broker isn't so rosy on the outlook for Cochlear shares in 2022, urging its clients to either sell or downsize their positions.

TradingView Chart

Why does this broker say sell Cochlear shares?

Analysts at RBC Capital Markets are cautious about the hearing specialist given the company's slowing sales growth and questionable valuation.

The broker initiated coverage on the Cochlear share price and anticipates it to underperform in 2022. It notes its revenue growth has fallen off, alongside other growth metrics in recent times.

This means Cochlear no longer commands the valuation premium it once did, seeing as cash flows into the future don't appear to be as large as first thought.

Not only that, but the seniors market for hearing technology is becoming more saturated, meaning Cochlear runs the risk of losing market share to competitors in that space, RBC says.

RBC values the company at a significantly discounted $149 per share, suggesting a downside potential of 31% at the time of writing.

It's not all downbeat – one broker upgrades to neutral

Meanwhile, analysts at fellow broker Morgan Stanley note that Cochlear's annual guidance looks to be a bit soft, even amid the weakening sales outlook.

The broker reckons Cochlear will offset the tightening sales through service and upgrade revenue which it feels will continue to hold strong in FY22.

For reference, Cochlear grew services revenue by 21% year on year and acoustics sales were 40% higher from the same time last year.

Given its healthy assessment on the stock, Morgan Stanley upgraded its rating to equal-weight from underweight to reflect the more positive sentiment.

It values Cochlear at $208 per share after raising its price target by 16% in a recent note.

The consensus price target for Cochlear is $221 per share, according to Bloomberg Intelligence, meaning the sentiment is still bullish from the 21 analysts covering the stock.

In fact, 42.1% have it as a buy, another 42.1% have it as a hold right now, with the remaining 15.8% advocating to sell Cochlear shares.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Delighted adult man, working on a company slogan, on his laptop.
Broker Notes

Broker tips 20% upside for these ASX utilities shares

Bell Potter sees upside in these two shares.

Read more »

A beautiful woman with brown hair and wearing bright red lipstick looks shocked as she holds her hand to her cheek in response to the crumbling Adore Beauty share price today
Broker Notes

3 ASX consumer sector shares to avoid in July: expert

If you're looking to buy ASX consumer shares in July, read on.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Broker Notes

106% upside? Expert says this ASX All Ords small cap mining stock could explode

Big upside potential.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Buy the dip on these 2 ASX 200 shares: experts

Experts say these 2 ASX 200 shares are a buying opportunity today.

Read more »

A woman walks along the street holding an oversized box wrapped as a gift.
Broker Notes

Fundie reveals why these 3 ASX 200 large-cap shares ripped 35% to 96% in FY25

Blackwattle Investment Partners discusses the performance and outlook for 3 ASX 200 shares in its Large Cap Quality Fund.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Broker Notes

This fund manager just delivered a stellar year and he's bullish on these 5 stocks

With standout returns in both Australian and global equities, Andrew Mitchell shares five high-conviction stocks primed for long-term growth.

Read more »

A woman ponders over what to buy as she looks at the shelves of a supermarket.
Broker Notes

Does Macquarie prefer Woolworths or Coles shares today?

Which supermarket giant was recently named the favourite?

Read more »

Happy couple with a car dealer.
Broker Notes

Why this ASX All Ords stock could return 20%

The team at Macquarie believes this stock could be cheap at current levels.

Read more »